Related Experiment Videos
Model of a ternary complex between activated factor VII, tissue factor and factor IX
Shu-wen W Chen1, Jean-Luc Pellequer, Jean-François Schved
1CEA Valrhô-Site de Marcoule, DSV/DIEP/SBTN, Bagnols-sur-Cèze, France.
Thrombosis and Haemostasis
|August 3, 2002
Summary
Researchers modeled the three-dimensional structure of the FVIIa:TF:FIX complex, crucial for blood coagulation. This model aids in understanding coagulation initiation and developing new therapies targeting the FVIIa:TF:substrate complex.
Area of Science:
- Biochemistry
- Molecular Biology
- Structural Biology
Background:
- Coagulation factor VIIa (FVIIa) initiates blood clotting by activating factors IX (FIX) and X (FX) upon binding to tissue factor (TF).
- Understanding the molecular recognition mechanisms in this initial step is critical for comprehending coagulation regulation.
Purpose of the Study:
- To elucidate the recognition mechanisms in the initiation of the coagulation cascade.
- To present a three-dimensional model of the ternary complex FVIIa:TF:FIX.
Main Methods:
- A three-dimensional model of the FVIIa:TF:FIX complex was constructed using a full-space search algorithm and computational graphics.
- Factor IX (FIX) docking was performed sequentially on a fixed FVIIa:TF crystallographic complex.
- A chimeric FIX molecule was engineered to address missing structural data for the FIX Gla domain.
Main Results:
- The study presents a validated three-dimensional model of the FVIIa:TF:FIX complex.
- The model was rigorously tested against diverse experimental data, including mutagenesis, peptide inhibition, and antibody data.
- The model successfully explains mutations associated with hemophilia B.
Conclusions:
- The developed FVIIa:TF:FIX complex model is a valuable tool for studying FVIIa production regulation.
- This structural insight opens new therapeutic avenues for developing inhibitors of the FVIIa:TF:substrate complex.